“…Furthermore, the antifibrotic agent used to treat IPF, Pirfenidone, has been shown to induce cell cycle arrest (Ruwanpura et al, 2020, Sun et al, 2018, Usugi et al, 2019). Reduced cell apoptosis, cell cycle regulation through p21 ( cdkn1a )(Jablonski et al, 2019, Bedelbaeva et al, 2010), p53 ( trp53 ), and p16 ( cdkn2a ), increased cell proliferation(Bedelbaeva et al, 2010), and enhanced stem cell function(Naviaux et al, 2009) may command augmented regenerative capacity. Given that PTEN, a tumor suppressor gene, is a natural inhibitor of the phosphoinositide 3-kinase (PI3K) and of the mammalian target of rapamycin (mTOR) pathway, the negative enrichment of PTEN regulated genes provide a mechanistic link between mTOR-regulated cell cycle and scar healing in tendon.…”